Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · IEX Real-Time Price · USD
4.500
+0.350 (8.43%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Kiora Pharmaceuticals Employees
Kiora Pharmaceuticals had 12 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,333,333
Profits / Employee
$189,739
Market Cap
13.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Universe Pharmaceuticals INC | 225 |
Psychemedics | 116 |
Flora Growth | 108 |
Addex Therapeutics | 23 |
Avalo Therapeutics | 19 |
NeuroSense Therapeutics | 18 |
QT Imaging Holdings | 14 |
XTL Biopharmaceuticals | 7 |
KPRX News
- 12 days ago - Kiora Pharmaceuticals to Participate in Jones Healthcare Seaside Summit 2024; Kiora Invites Investors to Submit Questions Following the Conference Presentation - Newsfile Corp
- 21 days ago - Biotech Executive Lisa Walters-Hoffert Joins Kiora Pharmaceuticals' Board of Directors - Newsfile Corp
- 27 days ago - Vitreoretinal Surgeon and Key Thought Leader Roger Goldberg, M.D., Joins Kiora Pharmaceuticals' Scientific Advisory Board - Newsfile Corp
- 2 months ago - Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences - Newsfile Corp
- 2 months ago - Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease - Newsfile Corp
- 2 months ago - Kiora Pharmaceuticals to Present at The Citizens JMP Life Sciences Conference - Newsfile Corp
- 2 months ago - Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa - Newsfile Corp
- 3 months ago - Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study - Newsfile Corp